The aetiology of pouchitis in patients with inflammatory bowel disease.
IBD
pouchitis
ulcerative colitis
Journal
Therapeutic advances in gastroenterology
ISSN: 1756-283X
Titre abrégé: Therap Adv Gastroenterol
Pays: England
ID NLM: 101478893
Informations de publication
Date de publication:
2024
2024
Historique:
received:
06
01
2024
accepted:
08
04
2024
medline:
30
5
2024
pubmed:
30
5
2024
entrez:
30
5
2024
Statut:
epublish
Résumé
Restorative proctocolectomy with ileal pouch-anal anastomosis is a treatment option for patients with refractory ulcerative colitis. Pouchitis is the most common complication, representing a spectrum of diseases ranging from acute antibiotic-responsive type to chronic antibiotic-refractory. Early accurate diagnosis using a combined assessment of symptoms, endoscopy and histology is important for both treatment and prognostication. Most patients respond well to antibiotic therapy; however, management of chronic antibiotic-refractory pouchitis remains a challenge, and treatment options are based on small studies. Pouchitis is thought to be driven by the interaction between genetics, the immune system and the environment but as yet a causal relationship has yet to be identified. Further longitudinal assessment of the pouch integrating new technologies may help us understand the factors driving pouchitis. This review outlines the currently understood risk factors and aetiology of pouchitis.
Identifiants
pubmed: 38812704
doi: 10.1177/17562848241249449
pii: 10.1177_17562848241249449
pmc: PMC11135114
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
17562848241249449Informations de copyright
© The Author(s), 2024.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest.